Schedule 13G ownership disclosure

ACURA PHARMACEUTICALS, INC

Security class unavailable · CUSIP: 00509L703

Event date: 2016-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
103,444
Percent of class
0.8700%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001535610-17-000023
Form type
SC 13G/A
Filer
ACURA PHARMACEUTICALS, INC
CIK
CIK 786947
Filed
Jan 09, 2017
Reporting period
Dec 31, 2016
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub